Randomized Trial Comparing Cisplatin, Gemcitabine, and Vinorelbine With Either Cisplatin and Gemcitabine or Cisplatin and Vinorelbine in Advanced Non–Small-Cell Lung Cancer: Interim Analysis of a Phase III Trial of the Southern Italy Cooperative Oncology GroupPasquale Comella, Giuseppe Comella, Michèle Natale et al.|Journal of Clinical Oncology|2000Cited by 177
Cisplatin, Gemcitabine, and Vinorelbine Combination Therapy in Advanced Non–Small-Cell Lung Cancer: A Phase II Randomized Study of the Southern Italy Cooperative Oncology GroupPasquale Comella, Giuseppe Comella, G. Frasci et al.|Journal of Clinical Oncology|1999Cited by 73
Cisplatin, Gemcitabine, and Paclitaxel in Locally Advanced or Metastatic Non–Small-Cell Lung Cancer: A Phase I-II StudyG. Frasci, Giuseppe Comella, Nicola Panza et al.|Journal of Clinical Oncology|1999Cited by 54
Interim Analysis of a Phase III Trial Comparing Cisplatin, Gemcitabine, and Vinorelbine vs. Either Cisplatin and Gemcitabine or Cisplatin and Vinorelbine in Advanced Non–Small-Cell Lung Cancer. A Southern Italy Cooperative Oncology Group StudyPasquale Comella, Giuseppe Comella, Nicola Panza et al.|Clinical Lung Cancer|2000Cited by 10
231 Gemcitabine (GEM)-cisplatin (CDDP)-vinorelbine (VNR) combination in advanced non-small-cell lung cancer (NSCLC). A phase II randomized studyP. Comella, G. Comella, N. Panza et al.|Lung Cancer|1997Cited by 7